David Buck
Stock Analyst at B. Riley Securities
(n/a)
# 4,807
Out of 4,829 analysts
14
Total ratings
n/a
Success rate
-14.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Buck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNOV MediciNova | Assumes: Buy | $22 | $1.44 | +1,427.96% | 2 | Mar 25, 2019 | |
| SUPN Supernus Pharmaceuticals | Maintains: Buy | $68 → $65 | $32.21 | +101.80% | 3 | Nov 12, 2018 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $219 → $190 | $103.58 | +83.43% | 4 | Nov 8, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $26 → $28 | $7.60 | +268.66% | 2 | Aug 22, 2018 | |
| ALKS Alkermes | Initiates: Buy | $60 | $31.26 | +91.97% | 1 | Jun 6, 2018 | |
| EVOK Evoke Pharma | Reinstates: Buy | $1,440 | $3.16 | +45,541.84% | 2 | Oct 19, 2017 |
MediciNova
Mar 25, 2019
Assumes: Buy
Price Target: $22
Current: $1.44
Upside: +1,427.96%
Supernus Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $68 → $65
Current: $32.21
Upside: +101.80%
Jazz Pharmaceuticals
Nov 8, 2018
Maintains: Buy
Price Target: $219 → $190
Current: $103.58
Upside: +83.43%
Amneal Pharmaceuticals
Aug 22, 2018
Maintains: Buy
Price Target: $26 → $28
Current: $7.60
Upside: +268.66%
Alkermes
Jun 6, 2018
Initiates: Buy
Price Target: $60
Current: $31.26
Upside: +91.97%
Evoke Pharma
Oct 19, 2017
Reinstates: Buy
Price Target: $1,440
Current: $3.16
Upside: +45,541.84%